SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000850261-18-000015
Filing Date
2018-03-19
Accepted
2018-03-19 19:40:31
Documents
2
Period of Report
2018-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_152150281390175.html 3  
1 FORM 3 wf-form3_152150281390175.xml 3 3075
2 SHAO POWER OF ATTORNEY sti-powerofattorneysection.htm EX-24 3410
  Complete submission text file 0000850261-18-000015.txt   7974
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address SUITE 1003-1004, 10/F, ICBC TOWER THREE GARDEN ROAD, CENTRAL HONG KONG F4 000000
Business Address
Shao Jiong (Reporting) CIK: 0001720540 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36150 | Film No.: 18700325